Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Roopal Thakkar is EVP, R&D and CSO at AbbVie. OQRO lists 6 transactions filed with the SEC under this name, the latest on Mar 3, 2026, each linked to the official Form 4.
EVP, R&D and CSO
Disclosures on record
6
Companies involved
1
AbbVieABBV
6 disclosures · Feb 2026 – Mar 2026
Feb 27, 20268,037disclosed Mar 3
DetailsOfficial recordFeb 18, 20266,015disclosed Feb 20
DetailsOfficial recordFeb 18, 20262,138disclosed Feb 20
DetailsOfficial recordFeb 18, 20263,346disclosed Feb 20
DetailsOfficial recordFeb 18, 20266,638disclosed Feb 20
DetailsOfficial recordFeb 18, 202622Kdisclosed Feb 20
DetailsOfficial recordAs of the latest filing on , Roopal Thakkar reported holding 52,376 shares of AbbVie (ABBV), worth about $15.4M at the last close of $295 (Nov 16, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| AbbVie ABBV | 52,376 | 52K direct | $295 | $15.4M | Feb 27, 2026 |
Is this Roopal Thakkar’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Feb 27, 2026, Roopal Thakkar reported holding 52,376 shares of AbbVie (ABBV). At the last close of $295 on Nov 16, 2026, that is about $15.4M. This is the stake disclosed in filings, not a net worth.